Table 4.

Genetic Disorders Associated with Acromegaly (233,234)

Genetic conditionGene implicatedInheritanceClinical features
X-LAGGPR101X-linked dominant or sporadicMostly females
Age <5 years
Hyperprolactinemia at diagnosis
Can be de-novo and family history may be absent
Familial isolated pituitary adenomaAIPAutosomal dominant or sporadicYounger males
Higher GH levels
Poor response to SSA therapy
MEN1MEN1Autosomal dominant or sporadicPresence of primary hyperparathyroidism, pancreatic disease along with pituitary adenoma
MEN4CDKN1BAutosomal dominantPresence of pituitary and
parathyroid neoplasms with pheochromocytomas, thyroid and other tumors
Carney complexPRKAR1AAutosomal dominantSkin pigmentation, Atrial myxoma, GH or PRL excess, Cushing’s due to primary pigmented nodular adrenocortical disease
Somatrotroph hyperplasia or multifocal adenoma
Mc Cune AlbrightGNASAutosomal dominant or sporadicAverage age of diagnosis 23 years
Acromegaly seen in 20-30% cases
Hyperprolactinemia present at diagnosis
Café-au-lait spots
Peripheral Precocious puberty
Somatrotroph hyperplasia
SDH mutationSDHxAutosomal dominant or sporadicPhaeochromocytoma, paraganglioma and primary hyperparathyroidism present
NeurofibromatosisNF1Autosomal dominantFew case reports of children and adolescents with optic glioma, rarely adenoma reported
Mechanisms unclear

From: Acromegaly

Cover of Endotext
Endotext [Internet].
Feingold KR, Anawalt B, Blackman MR, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
Copyright © 2000-2024, MDText.com, Inc.

This electronic version has been made freely available under a Creative Commons (CC-BY-NC-ND) license. A copy of the license can be viewed at http://creativecommons.org/licenses/by-nc-nd/2.0/.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.